Clinical Trial Update: Lymph Node Mapping in Finding Metastatic Disease in Patients With Sebaceous Gland Cancer of the Eyelid [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluating lymph node mapping to detect metastatic disease in patients with eyelid sebaceous gland carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sebaceous Gland Carcinoma of the Eyelid

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Eyelid Sebaceous Gland Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2025-07-04